AGE
Price:
$11.1
Market Cap:
$33.27M
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation...[Read more]
Industry
Biotechnology
IPO Date
2018-11-29
Stock Exchange
AMEX
Ticker
AGE
According to AgeX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.42M. This represents a change of -49.11% compared to the average of 53.87M of the last 4 quarters.
The mean historical Enterprise Value of AgeX Therapeutics, Inc. over the last ten years is 71.00M. The current 27.42M Enterprise Value has changed 3.76% with respect to the historical average. Over the past ten years (40 quarters), AGE's Enterprise Value was at its highest in in the March 2019 quarter at 136.02M. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.
Average
71.00M
Median
68.49M
Minimum
22.54M
Maximum
119.71M
Discovering the peaks and valleys of AgeX Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 431.07%
Maximum Annual Enterprise Value = 119.71M
Minimum Annual Increase = -72.05%
Minimum Annual Enterprise Value = 22.54M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 33.46M | -72.05% |
| 2023 | 119.71M | 431.07% |
| 2022 | 22.54M | -46.35% |
| 2021 | 42.02M | -34.26% |
| 2020 | 63.92M | -6.67% |
| 2019 | 68.49M | -31.03% |
| 2018 | 99.31M | 8.85% |
| 2017 | 91.23M | -7.24% |
The current Enterprise Value of AgeX Therapeutics, Inc. (AGE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
58.57M
5-year avg
56.33M
10-year avg
71.00M
AgeX Therapeutics, Inc.’s Enterprise Value is greater than Freeline Therapeutics Holdings plc (-13071904.00), greater than Liminal BioSciences Inc. (2.38M), greater than Vincerx Pharma, Inc. (-4374189.00), less than AnPac Bio-Medical Science Co., Ltd. (200.74M), greater than Angion Biomedica Corp. (14.84M), greater than Allakos Inc. (5.52M), less than Gemini Therapeutics, Inc. (0), less than Marinus Pharmaceuticals, Inc. (44.18M), less than LakeShore Biopharma Co., Ltd (624.72M), less than SmileDirectClub, Inc. (778.69M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -13071904.00 | $28.28M | |
| 2.38M | $27.62M | |
| -4374189.00 | $62.81K | |
| 200.74M | $26.97M | |
| 14.84M | $30.11M | |
| 5.52M | $29.74M | |
| 0 | $25.49M | |
| 44.18M | $30.37M | |
| 624.72M | $25.84M | |
| 778.69M | $13.39K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgeX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AgeX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AgeX Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AgeX Therapeutics, Inc. (AGE)?
What is the 3-year average Enterprise Value for AgeX Therapeutics, Inc. (AGE)?
What is the 5-year average Enterprise Value for AgeX Therapeutics, Inc. (AGE)?
How does the current Enterprise Value for AgeX Therapeutics, Inc. (AGE) compare to its historical average?